Towards better diagnosis of neurodegenerative disorders: Skin biopsy for α-synuclein detection proves effective

FHS
March 26, 2024
10:20 am

The positivity rate of cutaneous phosphorylated alpha-synuclein protein (P-SYN) deposition among individuals with dementia.

Engine Biosciences bags $27M Series A extension to advance precision medicine platform in oncology

Engine Biosciences has raised $27 million in a Series A extension with an eye to advance its discovery-stage precision oncology programs, which leverage both machine

November 1, 2023

Gerresheimer on track to another strong financial year – Biotech Investments

EQS-News: Gerresheimer AG / Key word(s): Quarterly / Interim Statement/9 Month figures Gerresheimer AG: Gerresheimer on track to another strong financial year 05.10.2023 / 07:00

October 6, 2023

Upfront Ezetimibe in ACS; New Watchman LAA Occluder OK’d; Low-Cost FH Genotyping

Compared with statins alone, upfront dual therapy with a statin and ezetimibe (Zetia) was associated with better survival in acute coronary syndrome, a Polish registry

September 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.